PLIVA 517 (Metoclopramide 5 mg)
Pill imprint PLIVA 517 has been identified as Metoclopramide hydrochloride 5 mg.
Metoclopramide is used in the treatment of gastroparesis; nausea/vomiting; migraine; gerd; lactation augmentation (and more), and belongs to the drug classes GI stimulants, miscellaneous antiemetics. There is no proven risk in humans during pregnancy. Metoclopramide 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- PLIVA 517
- Strength:
- 5 mg
- Color:
- Green
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- GI stimulants
Miscellaneous antiemetics - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
More about metoclopramide
Consumer resources
- Metoclopramide
- Metoclopramide orally disintegrating tablets
- Metoclopramide solution
- Metoclopramide syrup
- Metoclopramide (Advanced Reading)
- Metoclopramide Intravenous (Advanced Reading)
- Other brands: Reglan, Metozolv ODT
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
